• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异维 A 酸治疗伴有和不伴有多囊卵巢综合征的结节性囊肿性痤疮:疗效和复发的决定因素。

Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome: efficacy and determinants of relapse.

机构信息

Department of Dermatology, Etimesgut State Hospital, Ankara, Turkey.

出版信息

Int J Dermatol. 2013 Mar;52(3):371-6. doi: 10.1111/j.1365-4632.2012.05691.x. Epub 2012 Sep 24.

DOI:10.1111/j.1365-4632.2012.05691.x
PMID:22998438
Abstract

BACKGROUND

Isotretinoin is the most efficacious long-lasting treatment for acne; however, some factors, including polycystic ovary syndrome (PCOS), patient age, family history, and type and number of acne lesions, may lead to treatment resistance or relapse following treatment. The aim of this study was to compare the efficacy and permanence of systemic isotretinoin (SI) in nodulocystic acne patients with and without PCOS and to evaluate the factors associated with relapse during the first and second post-treatment years.

METHODS AND MATERIALS

The study included 96 female patients with nodulocystic acne. SI 0.5-1 mg/kg/dl was given, with a total cumulative dose of 120-150 mg/kg. Response to treatment and relapse during the first and second post-treatment years were evaluated.

RESULTS

In all, the 50 non-PCOS and 46 PCOS acne patients were similar. SI was similarly efficacious in both groups. In total, eight patients relapsed during the first post-treatment year, versus 16 during the second. Relapse during the first year was associated with the number of nodules at the start of treatment and the number of papulopustular lesions at the end of treatment, whereas PCOS, patient age, and the number of nodules at the start of treatment were associated relapse during the second year.

CONCLUSION

Regardless of its association with PCOS, SI was effective in the treatment of nodulocystic acne. The factors associated with relapse during the 1(st) and 2(nd) post-treatment years differed, except for the number of nodules at the start of treatment.

摘要

背景

异维 A 酸是治疗痤疮最有效的长期治疗方法;然而,一些因素,包括多囊卵巢综合征(PCOS)、患者年龄、家族史以及痤疮病变的类型和数量,可能导致治疗抵抗或治疗后复发。本研究旨在比较伴有和不伴有 PCOS 的结节囊肿性痤疮患者全身用异维 A 酸(SI)的疗效和持久性,并评估治疗后第 1 年和第 2 年复发的相关因素。

方法和材料

该研究纳入了 96 例女性结节囊肿性痤疮患者。给予异维 A 酸 0.5-1mg/kg/dl,总累积剂量为 120-150mg/kg。评估治疗反应和治疗后第 1 年和第 2 年的复发情况。

结果

共 50 例非 PCOS 痤疮患者和 46 例 PCOS 痤疮患者相似。两组 SI 疗效相似。共有 8 例患者在治疗后第 1 年复发,16 例患者在第 2 年复发。第 1 年复发与治疗开始时的结节数量和治疗结束时的丘疹脓疱性病变数量有关,而 PCOS、患者年龄和治疗开始时的结节数量与第 2 年的复发有关。

结论

无论是否与 PCOS 相关,SI 对结节囊肿性痤疮的治疗均有效。治疗后第 1 年和第 2 年复发的相关因素不同,除了治疗开始时的结节数量。

相似文献

1
Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome: efficacy and determinants of relapse.异维 A 酸治疗伴有和不伴有多囊卵巢综合征的结节性囊肿性痤疮:疗效和复发的决定因素。
Int J Dermatol. 2013 Mar;52(3):371-6. doi: 10.1111/j.1365-4632.2012.05691.x. Epub 2012 Sep 24.
2
Fire needle pretreatment with 5-aminolevulinic acid photodynamic therapy combined with low-dose isotretinoin in the treatment of severe refractory nodulocystic acne.火针预处理联合小剂量异维 A 酸和 5-氨基酮戊酸光动力疗法治疗中重度结节囊肿性痤疮
Photodiagnosis Photodyn Ther. 2024 Jun;47:104215. doi: 10.1016/j.pdpdt.2024.104215. Epub 2024 May 11.
3
The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome.口服异维 A 酸治疗痤疮合并多囊卵巢综合征女性的疗效。
Biomed Res Int. 2019 Apr 7;2019:2513067. doi: 10.1155/2019/2513067. eCollection 2019.
4
The impact of oral isotretinoin on ovarian functions of acne patients complaining of polycystic ovarian syndrome: a prospective study.口服异维 A 酸对多囊卵巢综合征患者痤疮患者卵巢功能的影响:一项前瞻性研究。
J Ovarian Res. 2024 Jan 20;17(1):21. doi: 10.1186/s13048-024-01347-x.
5
High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.大剂量异维 A 酸治疗痤疮患者的再诉、复发和不良反应率。
JAMA Dermatol. 2013 Dec;149(12):1392-8. doi: 10.1001/jamadermatol.2013.6746.
6
Treatment of acne with isotretinoin: recommendations based on Australian experience.异维A酸治疗痤疮:基于澳大利亚经验的建议。
Australas J Dermatol. 2003 May;44(2):97-105. doi: 10.1046/j.1440-0960.2003.00653.x.
7
Low-dose schema of isotretinoin in acne vulgaris.异维A酸低剂量方案治疗寻常痤疮
Int J Clin Pharmacol Res. 2003;23(2-3):41-6.
8
Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients.异维A酸治疗后痤疮复发:405例患者的回顾性研究
J Drugs Dermatol. 2008 Oct;7(10):963-6.
9
[Second joint position paper: Use of isotretinoin in severe acne].[第二篇联合立场文件:异维A酸在重度痤疮治疗中的应用]
Rev Med Inst Mex Seguro Soc. 2019 Jan 28;56(5):441-446.
10
High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.寻常痤疮给予大剂量异维 A 酸治疗:改善治疗结局和生活质量。
Int J Dermatol. 2012 Sep;51(9):1123-30. doi: 10.1111/j.1365-4632.2011.05409.x.

引用本文的文献

1
Acne Relapse and Isotretinoin Retrial in Patients With Acne.痤疮复发与痤疮患者异维A酸再治疗
JAMA Dermatol. 2025 Apr 1;161(4):367-374. doi: 10.1001/jamadermatol.2024.5416.